per the company's latest investor update (1/20/21), Brilacidin has only been tested on the Washington and Italian variants of CV19.
The quote referenced is false and unsubstantiated without qualified external citation.
There's a reason no link or citation was provided in the original post. Perhaps you're aware that unscrupulous actors will twist and embellish facts - rendering said facts as half-truths - for financial benefit?